201 related articles for article (PubMed ID: 17597184)
1. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
[TBL] [Abstract][Full Text] [Related]
2. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
3. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
6. Cellular interactions of the phosphorylated form of AKT in prostate cancer.
Hammerich KH; Frolov A; Li R; Ittmann M; Ayala GE
Hum Pathol; 2017 May; 63():98-109. PubMed ID: 28300578
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic accumulation of glycogen synthase kinase-3beta is associated with aggressive clinicopathological features in human prostate cancer.
Li R; Erdamar S; Dai H; Sayeeduddin M; Frolov A; Wheeler TM; Ayala GE
Anticancer Res; 2009 Jun; 29(6):2077-81. PubMed ID: 19528467
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of FOXO1 in non-small cell lung cancer.
Maekawa T; Maniwa Y; Doi T; Nishio W; Yoshimura M; Ohbayashi C; Hayashi Y; Okita Y
Oncol Rep; 2009 Jul; 22(1):57-64. PubMed ID: 19513505
[TBL] [Abstract][Full Text] [Related]
9. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
[TBL] [Abstract][Full Text] [Related]
10. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C
BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967
[TBL] [Abstract][Full Text] [Related]
11. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
12. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients.
Le Page C; Koumakpayi IH; Alam-Fahmy M; Mes-Masson AM; Saad F
Br J Cancer; 2006 Jun; 94(12):1906-12. PubMed ID: 16721361
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
Li R; Dai H; Wheeler TM; Sayeeduddin M; Scardino PT; Frolov A; Ayala GE
Clin Cancer Res; 2009 May; 15(10):3568-73. PubMed ID: 19417030
[TBL] [Abstract][Full Text] [Related]
14. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.
Bravou V; Klironomos G; Papadaki E; Taraviras S; Varakis J
J Pathol; 2006 Jan; 208(1):91-9. PubMed ID: 16278819
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of activated AKT expression in soft-tissue sarcoma.
Tomita Y; Morooka T; Hoshida Y; Zhang B; Qiu Y; Nakamichi I; Hamada K; Ueda T; Naka N; Kudawara I; Aozasa K
Clin Cancer Res; 2006 May; 12(10):3070-7. PubMed ID: 16707604
[TBL] [Abstract][Full Text] [Related]
17. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
18. Expression of neutral amino acid transporter ASCT2 in human prostate.
Li R; Younes M; Frolov A; Wheeler TM; Scardino P; Ohori M; Ayala G
Anticancer Res; 2003; 23(4):3413-8. PubMed ID: 12926082
[TBL] [Abstract][Full Text] [Related]
19. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.
Rhodes DR; Sanda MG; Otte AP; Chinnaiyan AM; Rubin MA
J Natl Cancer Inst; 2003 May; 95(9):661-8. PubMed ID: 12734317
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer.
Rodríguez-Berriguete G; Sánchez-Espiridión B; Cansino JR; Olmedilla G; Martínez-Onsurbe P; Sánchez-Chapado M; Paniagua R; Fraile B; Royuela M
Cytokine; 2013 Nov; 64(2):555-63. PubMed ID: 24063999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
